Finance

Lists
600521:SHA
Zhejiang Huahai Pharmaceutical Co., Ltd.
CNÂ¥15.99
-0.74%
(-0.12) 1D
Sep 4, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600521...
Open
CNÂ¥16.10
High
CNÂ¥16.17
Low
CNÂ¥15.96
Mkt. cap
23.91B
Avg. vol.
37.75M
Volume
18.59M
Dividend
0.63%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 18, 2026
P/E ratio
37.60
52-wk high
CNÂ¥27.97
52-wk low
CNÂ¥13.73
EPS
CNÂ¥0.43
Shares outstanding
1.25B
No. of employees
9K
Open
CNÂ¥16.10
High
CNÂ¥16.17
Low
CNÂ¥15.96
Mkt. cap
23.91B
Avg. vol.
37.75M
Volume
18.59M
Dividend
0.63%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 18, 2026
P/E ratio
37.60
52-wk high
CNÂ¥27.97
52-wk low
CNÂ¥13.73
EPS
CNÂ¥0.43
Shares outstanding
1.25B
No. of employees
9K
About Zhejiang Huahai Pharmaceutical Co., Ltd.
CEO-
Employees8.8K
Founded1989
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.89B
2.18B
2.34B
2.58B
Cost of goods sold
743.42M
1.13B
988.64M
1.05B
Cost of revenue
743.42M
1.13B
988.64M
1.05B
Research and development expenses
306.29M
399.64M
218.54M
244.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
766.84M
703.66M
810.07M
756.82M
Operating expense
1.02B
1.15B
1.04B
990.10M
Total operating expenses
1.76B
2.28B
2.03B
2.04B
Operating income
129.57M
-104.23M
308.31M
532.54M
Other non operating income
-16.70M
14.72M
-46.77M
-117.18M
EBT including unusual items
6.30M
-105.28M
444.33M
457.70M
EBT excluding unusual items
70.67M
-177.11M
447.80M
440.22M
Income tax expense
37.52M
41.32M
45.99M
88.96M
Effective tax rate
596.03%
-39.25%
10.35%
19.44%
Other operating expenses
-36.90M
51.48M
-3.20M
1.85M
Net income
-29.13M
-113.96M
404.18M
366.73M
Net profit margin
-1.54%
-5.23%
17.31%
14.23%
Earnings per share
-
-
-
-
Interest and investment income
23.14M
6.97M
249.37M
63.11M
Interest expense
-59.24M
-58.06M
-63.11M
-38.25M
Net interest expenses
-36.10M
-51.09M
186.27M
24.86M
Depreciation and amortization charges
-
-
-
-
EBITDA
350.99M
138.33M
550.87M
805.54M
Gain or loss from assets sale
-14.07K
-943.00
-
-23.33M
AI content may include mistakes. Learn more
Google apps